ABVX

#898
Abivax SA American Depositary Shares
125.80 USD
+3.70%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
125.80
125.80
Годовой диапазон
5.59
148.83
Дневное изменение
+3.70%
Месячное изменение
+4.83%
6-месячное изменение
+28.09%
Годовое изменение
+2017.85%
Предыдущее закрытие
121.31
Открыть
125.80
Bid
Ask
Минимум
125.80
High
125.80
Объем
48
Открыть полный график

Financials

Обзор Отчетность Статистика
Квартал Год
Отчет о доходах Баланс Денежный поток
Значение 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Новости